Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole

Ceftobiprole is a cephalosporin with potent activity against methicillin (meticillin)-resistant Staphylococcus aureus (MRSA). In order to treat patients with severe staphylococcal pneumonia, it is important to understand the drug exposure required to mediate the killing of multiple log(10) cells in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Rodvold, Keith A., Nicolau, David P., Lodise, Thomas P., Khashab, Mohammed, Noel, Gary J., Kahn, James B., Gotfried, Mark, Murray, Sara A., Nicholson, Susan, Laohavaleeson, Somvadee, Tessier, Pamela R., Drusano, G. L.
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology (ASM) 2009
Sujets:
Pharmacology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2715607/
https://ncbi.nlm.nih.gov/pubmed/19451287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00144-09
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires